Ferring Pharmaceuticals is responsible for the commercialization of BioGaia, TuZen and VSL#3 probiotics in Canada. It is a research-driven biopharmaceutical company dedicated to researching, developing and marketing innovative treatments in a number of key therapeutic areas including reproductive health, urology and gastroenterology. Founded in 1950, it now operates from 60 countries and employs more than 5,000 people throughout the world.